A lost lesson
This past Tuesday Senseonics report results which as expected, well expected by us anyway, weren’t good. There really is no need to review the results however we can’t help but wonder if the Senseonics experience will be another lost lesson. Here is a company which has a good product, a product that works yet a product for which there is no real unmet need. Like so many diabetes device companies...
Virtual or not the rumors continue
The annual ADA conference this year may be virtual but that hasn’t stop the diabetes rumor mill from churning. Next to the release of clinical studies the second favorite activity at one of these things is gossip. And to be honest gossip is more popular but hey this is supposed to be a scientific conference, so people have to pretend to be interested in the presentations. Typically the exhibit hall...
Where is Tyler?
It seems try as we might we just can’t get Tyler from concept to a real insulin dosing system. Now just in case anyone has forgotten and not sure how anyone could as we have continually described that Tyler is an insulin dosing system that includes a connected insulin pen – which can either be a durable pen or a cap cover for a disposable pen – a CGM and...
Don’t worry be happy
To say that 2020 has been an interesting year is like saying the Sears, oops it's now called the Willis Tower is a tall building. First came COVID which has been followed by protests, rioting and looting. Yet by the way things are going in the wacky world of diabetes one would think life goes blissfully along. 1. Yesterday Big Mouth, oops we meant to say Bigfoot announced they have closed...
What we won’t miss
As we move into June this would have been the month the diabetes world gathered in Chicago for our annual confab. Thanks to COVID and now protests, riots Chicago is off limits and ADA is going virtual. While there will be many things we are going to miss there are some things we’re delighted we’ll be missing. 1. We’re just as good as Dexcom only cheaper. CGM continues to be hotter...
Let’s keep our eye on the real prize
Yesterday social media went wild with the President’s announcement that co-payments for insulin would be capped at $35 per month for Medicare patients. Many on the left rather than rejoicing in this news scolded the President for what is a politically motivated attempt to get the senior vote. According to most polls the President trails Biden in this important voting bloc. The President knows seniors vote, he knows he’s behind...
Virtual ADA
With the Memorial Day holiday now behind us summer beckons and our attention turns to the upcoming virtual ADA. Under normal circumstances this would be cause for celebration as the diabetes world would have gathered in this great city of Chicago. Yet as we all know these are not normal circumstances and while this city is still great it would be greater if our mayor opened up the lakefront, but...
What’s the outlook for Digital Health?
As the economy slowly reopens pretty much everyone is wondering what the new “normal” will look like. About the only thing that’s certain is life won’t go back to the way it was before COVID. Just as new procedures were put in place after 9/11 to protect our safety, new procedures will be put in place to protect our health. As we have become used to the procedures put in...
Crazy Times
Who would have predicted that on a day when Medtronic reports earnings it would be a secondary story in our wacky world. Before we get into the bigger news, which will come in a sperate post let’s take a look at the Medtronic earnings which for their diabetes unit continue to struggle. According to one of the slides used during the call; “U.S. Revenue: Declined high-teens, primarily due to new patient...
More bad news for Medtronic
Not like we needed any additional evidence that the Medtronic diabetes franchise is having a very difficult time more came along yesterday when IntriCon, one of their key suppliers reported results. Per the earnings release; “Revenue in IntriCon’s Medical business in the first quarter of 2020 was $16.4 million, a decrease from $20.8 million in the comparable prior-year period. The year over year decline was driven primarily by the COVID-19 impact...